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Abstract
Background: The subset of patients with essential tremor (ET) that develops Parkinson’s disease (PD) has not been fully clinically characterized.
Methods: Motor features were retrospectively reviewed in 18 ET patients who developed PD (ETRPD), 20 ET and 30 PD patients with similar ages and disease
durations.
Results: Fewer ETRPD than ET patients had widespread postural and/or action tremor (2/17 [11.8%] vs. 11/17 [64.7%]; p50.001) and marginally fewer had
cerebellar signs (1/15 [6.7%] vs. 6/18 [33.3%], p50.06). ETRPD patients required fewer ET medications than did their counterparts with ET (p50.001).
ETRPD patients and PD patients did not differ in UPDRS, Hoehn and Yahr, or Schwab and England scores (each p>0.14).
Discussion: ET patients who develop PD may have distinct pre-PD motor features compared to their counterparts with ET who do not develop co-existing PD.
Prospective studies are needed to evaluate the predictive value of these clinical features for the emergence of PD.
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Introduction
Evidence supports an association between Parkinson’s disease (PD)
and essential tremor (ET).1–3 A subset of ET patients might be at
higher risk of developing PD;2,4 however, this subset has yet to be fully
clinically characterized. The aim of these retrospective analyses was to
determine whether patients with both ET and PD (ETRPD) are
clinically distinct from ET patients in terms of certain motor features.
Our hypothesis was that ETRPD patients would have less severe
action tremor than ET patients. Also, previous studies2,5 have
suggested that the PD phenotype in ETRPD patients is less severe
than that of PD patients. We compared ETRPD patients with PD
patients to explore this issue as well. The overarching goal of these
analyses was to use these clinical data to further refine our




The clinical database of the Movement Disorder Program of
University of Louisville, KY, was used for the current analyses, which
were centered on three patient groups: 1) PD with previous diagnosis
of ET (ETRPD), 2) ET without PD (ET), and 3) PD without ET (PD).
Searching for the words ‘‘Parkinson’’ and ‘‘tremor’’ retrieved 387 and
110 patients, respectively. Of these, 319 and 64 charts, respectively,
were available. These charts were reviewed by a fourth year neurology
resident (R.M.S), with special interest and training in Movement
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Disorders, to locate patients with both the diagnosis of PD (meeting
UK Parkinson’s disease Brain Bank criteria6 for probable PD) and a
previous history of ET (fulfilling criteria of definite ET according to the
consensus statement of the Movement Disorder Society,7 if parkinso-
nian signs were not considered): 18 were identified. Although no
minimum time between ET and PD onset was specified, all but two
patients had latencies>5 years. Based on the observed age distribution
of the 18 ETRPD patients, ET patients and PD patients were selected
if >60 years old, in order to ensure age comparability among groups.
Similarly, PD duration in the PD group was restricted to #5 years in
order to ensure comparability of PD duration with ETRPD patients.
Seventy-four of the ‘‘Parkinson’’ charts reviewed met the above
inclusion criteria for the PD group (>60 years old,#5 years of PD and
UK Parkinson’s disease Brain Bank criteria6 for probable PD), and the
first 30 on an alphabetical list were selected. Of the 64 ‘‘tremor’’ charts
reviewed, 20 fulfilled inclusion criteria for the ET group (age >60
years old, definite ET according to the consensus statement of the
Movement Disorder Society7) and all 20 were selected.
Data abstraction
All clinical charts were reviewed (R.M.S.), and every third chart was
also reviewed by a movement disorder neurologist (A.C.) to ensure that
abstracted data were valid. To assess reviewer bias, a third reviewer
(E.G., a physician who was a research assistant in the Movement
Disorders division), who was blinded to the study hypothesis, reviewed
a random sample of 10 ETRPD patient charts, assessing the main
findings (anatomic distribution of tremor and number of ET
medications). There was high agreement between reviewers, indicating
that reviewer bias was not present. A data abstraction form included
self-reported family history (first-degree relatives) of ET or PD, age at
onset (based on first symptom) of PD and ET, and first parkinsonian
symptom, as well as data from the most recent visit. Data from the
most recent visited included age, anatomic distribution of tremor
(upper and lower limb postural and kinetic tremors, head tremor, and
voice tremor, based on both history and examination), ET medica-
tions, and data from the neurological examination. Other objective
data from the most recent visit included cerebellar signs, subscores of
the motor Unified Parkinson’s Disease Rating Scale8 (UPDRS) (rest
tremor, rigidity, bradykinesia, postural instability), total UPDRS score,
Hoehn and Yahr score,9 and Schwab and England10 score. Cerebellar
signs were coded as present if any of nystagmus, intention tremor or
dysmetria in the finger-to-nose or heel-to-knee maneuvers were
present. Rest tremor, bradykinesia, rigidity, and postural instability
(pull test) were coded as present when the UPDRS score was >1.
Widespread postural and/or action tremor indicated that tremor was
not restricted to the arms but also included the head, voice, or legs. To
compare ETRPD and PD patients, the highest UPDRS subscores
(right or left side) were used.
Data analyses
Statistical analysis was performed using the SPSS 10 (R.M.S.).
Parametric tests were used throughout (Chi-square test for categorical
variables and t-test or ANOVA for continuous variables). Statistical
significance was considered when p,0.05.
Results
Demographics (Table 1)
ETRPD, ET and PD patients had similar gender and age.
ETRPD vs. ET (Table 1)
ETRPD and ET patients had similar duration of ET. Fewer
ETRPD patients had widespread postural and/or action tremor at
their most recent visit, especially head tremor. Marginally fewer ETR
PD had cerebellar signs than did their counterparts with ET. ETRPD
patients required fewer ET medications at their most recent visit than
did their counterparts with ET. Family history of PD was nearly twice
as common in ETRPD, but the difference was not significant. As
expected, signs of parkinsonism were more common in ETRPD than
ET patients.
One could argue that, after receiving a diagnosis of PD, ET
symptoms and signs in ETRPD patients might receive less attention
(i.e., not commented on in clinical notes and not the focus of treatment
efforts). To assess this possibility, we performed sensitivity analyses.
ETRPD cases were stratified into two groups (mild PD vs. more
severe PD) based on the median UPDRS score. We hypothesized that
the presence of fewer ET signs in the group with more severe PD
would support the notion that PD signs were drawing attention away
from ET signs. By contrast, similar severity of ET in the two groups
would argue that PD signs were not drawing attention away from ET
signs. We found that a similar proportion of ET cases in each group
had widespread postural and/or action tremor (p50.72) and a similar
proportion of ET cases in each group required more than one
medication (p50.56).
ETRPD vs. PD (Table 1)
The latency between ET and PD onset was 19.3¡15.7 (range 2–64)
years. The majority (61.1%, 11/18) had a latency .10 years and, in
11.1% (2/18) it was ,5 years. The main PD phenotypes in the PD
group were tremor predominant or mixed tremor–bradykinesia–
rigidity (75.9%; 22/29). Family history of ET was more common in
ETRPD than PD patients. UPDRS scores were similar in the two
groups.
Discussion
ET patients are more likely to develop PD than controls11 and there
is growing clinical,1,2,4 imaging,12–14 and neuropathological15–17
evidence supporting a physiopathological link between ET and PD.
In this study, fewer ETRPD patients had widespread postural and/
or action tremor or cerebellar signs and they required fewer ET
medications than did their counterparts with ET. The duration of ET
was similar in these ETRPD and ET patients. One possible
explanation is that ET patients who are prone to developing PD have
a less severe ET phenotype than do their counterparts who do not
develop PD. An alternative explanation, which we cannot fully
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Table 1. Comparison of Demographic Characteristics and Motor Features of ETRPD, ET, and PD Patients
ETRPD (n518) ET (n520) PD (n530) Significance (p)
Demographic characteristics
Age at last visit (mean¡SD years) 74.4¡8.2 72.8¡8.1 71.0¡7.3 0.341
Gender (males: n; %) 13; 72.2% 11; 55.0% 21; 70.0% 0.453
ETRPD vs. ET
Age at onset of ET (mean¡SD years) 49.8¡18.6 47.6¡24.8 – 0.752
Duration of ET (mean¡SD years) 24.0¡15.6 25.4¡21.6 – 0.822
Duration of ET prior to PD onset
(mean¡SD years)
19.3¡15.7 – – –
Family history of ET (n; %) 9/17; 52.9% 11/20; 55.0% – 0.903
Family history of PD (n; %) 3/17; 17.6% 2/20; 10.0% – 0.503
Rest tremor (n; %) 13/16, 81.2% 5/19; 26.3% – ,0.0013
Bradykinesia (n; %) 11/12, 91.7% 3/18; 16.7% – ,0.00013
Rigidity (n; %) 11/12, 91.7% 5/19; 26.3% – ,0.00013
Postural instability (n; %) 4/16; 25.0% 1/17; 5.9% – 0.133
Cerebellar signs (n; %) 1/15, 6.7% 6/18, 33.3% – 0.063
Widespread postural and/or action tremor
(n; %)
2/17; 11.8% 11/17; 64.7% – 0.0013
Lower limb tremor (n; %) 1/17; 5.9% 4/17; 23.5% 0.153
Head tremor (n,%) 1/17; 5.9% 7/17; 41.2% 0.023
Voice tremor (n, %) 2/17; 11.8% 4/17; 23.5% 0.373
Need .1 medication for ET at most recent
visit (n; %)
2/17; 11.8% 12/18; 66.7% – 0.0013
ETRPD vs. PD
Age at onset of PD (mean¡SD years) 71.4¡10.1 – 67.7¡7.0 0.142
Duration of PD (mean¡SD years) 4.8¡7.6 – 3.8¡4.2 0.562
Family History of ET (n, %) 9/17; 52.9% – 2/24; 8.3% ,0.00013
Family history of PD (n; %) 5/17; 29.4% – 7/29; 24.1% 0.803
First symptom of PD
Rest tremor (n; %) 8/15; 53.3% – 19/27; 70.4% 0.183
Bradykinesia (n; %) 7/15; 46.7% – 6/27; 22.2%
Rigidity (n; %) 0/15; 0% – 2/27; 7.4%
UPDRS – rest tremor upper limb
(mean¡SD)2
1.3¡1.04 – 1.0¡1.04 0.252
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exclude, is that, after receiving a diagnosis of PD, ET symptoms and
signs in ETRPD patients received less attention (i.e., not commented
on in clinical notes and not the focus of treatment efforts). However,
our sensitivity analyses suggested that this was not the case.
ETRPD patients have previously been shown to have less severe
parkinsonism2,5 when compared to other PD patients. This was not
noted in the current dataset. This difference could be due to our small
sample size, retrospective design, short duration of PD (less than 5
years), and high proportion of PD patients with non-akinetic rigid
phenotypes, which are known to have a better motor outcome.18,19
This study has some limitations. First, the retrospective design and
the small sample size may have limited the power to detect
associations. It is possible that some group differences were only
detected as trends rather than statistically significant differences. This
being said, many significant associations were detected, indicating that
the sample size was adequate for those comparisons. Second, limb
postural, and kinetic tremors, head tremor, and voice tremor were
assessed during routine clinical care; however, a standardized, ordinal
tremor rating scale was not used; this may have biased the results
towards the null hypothesis by reducing precision and obscuring
differences between ET groups that may have been present.
In summary, our study suggests that ET patients who develop PD
may have distinct pre-PD motor features than their counterparts with
ET who do not develop co-existing PD. Prospective studies are now
needed to evaluate the predictive value of these clinical features for the
emergence of PD.
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